Talia Thompson

Dr. Talia Thompson


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2020 in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Verified
Journal Article
Closed access
PDF file
NTNicole Tartaglia
Nicole Tartaglia
SHSusan Howell
Susan Howell
SDShanlee Davis
Shanlee Davis
KKKaren Kowal
Karen Kowal
TTTanea Tanda
Tanea Tanda
JRJudith Ross
Judith Ross

23 January 2018 in Contemporary School Psychology
Verified
Journal Article
Closed access
PDF file
TTTalia Thompson
Talia Thompson
JCJeanine M. Coleman
Jeanine M. Coleman
KRKaren Riley
Karen Riley
LSLaurel A. Snider
Laurel A. Snider
LHLondi J. Howard
Londi J. Howard
DHDavid Hessl
David Hessl

25 May 2020 in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
Verified
Journal Article
Closed access
PDF file
TTTalia Thompson
Talia Thompson
SHSusan Howell
Susan Howell
SDShanlee Davis
Shanlee Davis
RWRebecca Wilson
Rebecca Wilson
JJJennifer Janusz
Jennifer Janusz
NTNicole Tartaglia
Nicole Tartaglia

16 September 2022 in Genes
Verified
Journal Article
Open access
PDF file
RLReymundo Lozano
Reymundo Lozano
TTTalia Thompson
Talia Thompson
JWJayne Dixon Weber
Jayne Dixon Weber
CECraig A. Erickson
Craig A. Erickson
EBElizabeth M. NA Berry-Kravis
Elizabeth M. NA Berry-Kravis
DHDavid Hessl
David Hessl
Caregiver reports, clinical observations, and diagnostic assessments indicate that most individuals with fragile X syndrome experience high levels of chronic anxiety. However, anxiety is a challenging endpoint for outcome measurement in FXS because most individuals cannot reliably report internal emotional or body states. A comprehensive survey of the presence, frequency, and duration of anxiety-related symptoms and questions to elicit open-ended responses was completed by caregivers of 456 individuals with FXS, ages 2–81 years (87 female, 369 male) and 24 female and 2 male FXS self-advocates ages 15–66 years. Caregivers reported classic behavioral indicators of anxiety, such as avoidance, irritability, motor agitation, and physiological symptoms, as well as behavioral features in FXS such as repetitive behavior, aggression, and self-injury. Self-advocate accounts largely paralleled caregiver data. Factor analyses yielded four factors: (1) increased irritability, aggression, and self-injury; (2) increased physical movement, nervous activity, and restlessness; (3) physical and physiological features of anxiety; and (4) internalizing and gastrointestinal symptoms. Caregivers are capable of observing and reporting behaviors that are valid indicators of anxious states that are usually reported in self-report standardized assessments. These results support the development of an anxiety measure for FXS that minimizes problems with rater inference.

8 December 2019 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
TTTalia Thompson
Talia Thompson
BZBrianna Zieba
Brianna Zieba
SHSusan Howell
Susan Howell
WKWilliam Karakash
William Karakash
SDShanlee Davis
Shanlee Davis

15 June 2020 in Journal of Applied Research in Intellectual Disabilities
Verified
Journal Article
Closed access
PDF file
TTTalia Thompson
Talia Thompson
DTDevadrita Talapatra
Devadrita Talapatra
CHCynthia E. Hazel
Cynthia E. Hazel
JCJeanine Coleman
Jeanine Coleman
NCNicholas Cutforth
Nicholas Cutforth